You are viewing the site in preview mode

Skip to main content


Fig. 2 | BMC Infectious Diseases

Fig. 2

From: Transient detectable viremia and the risk of viral rebound in patients from the Swiss HIV Cohort Study

Fig. 2

Survival curves given a patient reporting either complete adherence to antiretroviral therapy (left) or non-adherence to antiretroviral therapy (right) [24]. Curves are shown for the first suppression episode (top) and for subsequent suppression episodes (bottom). All curves are for the same reference patient: a male who did not acquire HIV though injection drug use, starting a suppression episode in 2005 at the age of 40, on a non-nucleoside reverse transcriptase based regimen, with a CD4 cell count of 350 cells/μL and with HIV RNA measured using an Amplicor ultrasensitive assay

Back to article page